awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33412684-40F11BC3-0A81-4865-A496-5946317C4C25
Q33412684-40F11BC3-0A81-4865-A496-5946317C4C25
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33412684-40F11BC3-0A81-4865-A496-5946317C4C25
A phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed/refractory myeloma
P2860
Q33412684-40F11BC3-0A81-4865-A496-5946317C4C25
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33412684-40F11BC3-0A81-4865-A496-5946317C4C25
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0bdfc3ac90ee1632e81348e1fe0064023fd82d53
P2860
Retreatment with bortezomib alone or in combination for patients with multiple myeloma following an initial response to bortezomib.